| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 555 |
| 1 | METHOTREXATE SODIUM | 534 |
| 2 | TOCILIZUMAB | 526 |
| 3 | DICLOFENAC SODIUM | 525 |
| 4 | DICLOFENAC | 521 |
| 5 | METHOTREXATE | 518 |
| 6 | ETANERCEPT | 508 |
| 7 | ADALIMUMAB-ADAZ | 504 |
| 8 | DESOXIMETASONE | 503 |
| 9 | FOLIC ACID | 503 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TRICLOSAN | 84 | 0.1456 |
| 1 | TRIPROLIDINE HYDROCHLORIDE | 19 | 0.0974 |
| 2 | CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE | 49 | 0.0745 |
| 3 | CLEAR MINT, GEL TOOTHPASTE | 70 | 0.0638 |
| 4 | SODIUM FLUORIDE F18 | 70 | 0.0633 |
| 5 | SODIUM FLUORIDE F-18 | 70 | 0.0632 |
| 6 | CAFFEINE CITRATE | 145 | 0.0621 |
| 7 | DICLOFENAC POTASSIUM TABLETS | 381 | 0.0439 |
| 8 | GOLIMUMAB | 493 | 0.0391 |
| 9 | BACITRACIN ZINC AND POLYMYXIN B SULFATE | 4 | 0.0360 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 578 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 562 |
| 2 | Interleukin-6 Receptor Antagonist [EPC] | 552 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 552 |
| 4 | Aminosalicylate [EPC] | 539 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 518 |
| 6 | Vitamin C [EPC] | 515 |
| 7 | Vitamin B12 [EPC] | 507 |
| 8 | Vitamin D [EPC] | 503 |
| 9 | Selective T Cell Costimulation Modulator [EPC] | 493 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 25 | 0.0363 |
| 1 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 127 | 0.0146 |
| 2 | Provitamin D2 Compound [EPC] | 319 | 0.0107 |
| 3 | Interleukin-17A Antagonist [EPC] | 372 | 0.0100 |
| 4 | Endoglycosidase [EPC] | 11 | 0.0059 |
| 5 | Aminosalicylate [EPC] | 539 | 0.0053 |
| 6 | Histamine-1 Receptor Antagonist [EPC] | 358 | 0.0042 |
| 7 | Tetracycline-class Drug [EPC] | 300 | 0.0042 |
| 8 | Antirheumatic Agent [EPC] | 438 | 0.0041 |
| 9 | Interleukin-12 Antagonist [EPC] | 414 | 0.0040 |